![Martin N. Bonde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin N. Bonde
Directeur Général chez
Bohrs Tower ApS
Profil
Martin N.
Bonde is the founder of Aros Pharma ApS, founded in 2009.
Dr. Bonde is the founder of Azanta Danmark AS, founded in 2000.
Dr. Bonde is also the founder of Torsana A,CelTor Biosystems, Inc.,Combio.
A,Arpida A. Dr. Bonde is the Chief Executive Officer at Bohrs Tower ApS.
Dr. Bonde is the Director at Visiopharm A. Dr. Bonde is the Director at Biotopix ApS.
Dr. Bonde is the Director at Bioinnovation Institute.
Dr. Bonde is the Director at Bii Holdings A. Dr. Bonde is the Member-Management Board at Bohrs Towers IVS.
Former jobs include Chief Executive Officer at EpiTherapeutics ApS.
Former jobs include Chief Executive Officer at Nykode Therapeutics ASA. Former jobs include Chief Executive Officer at Inthera Bioscience AG.
Former jobs include Chairman at Dansk Biotek.
Former jobs include Director at MycoTeQ A. Former jobs include Independent Director at Strategic Partners A from 2010 to 2022.
Former jobs included Principal at Arpida AG.
Former jobs include Principal at Azanta A. Education includes an undergraduate degree from Copenhagen Business School.
Education includes a graduate degree and a doctorate from Technical University of Denmark.
Postes actifs de Martin N. Bonde
| Sociétés | Poste | Début |
|---|---|---|
Visiopharm A/S
 Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Directeur/Membre du Conseil | - |
Bohrs Towers IVS | Corporate Officer/Principal | - |
Biotopix ApS | Directeur/Membre du Conseil | - |
Bohrs Tower ApS | Directeur Général | - |
Bioinnovation Institute
 Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Directeur/Membre du Conseil | - |
Bii Holdings A/S
 Bii Holdings A/S Miscellaneous Commercial ServicesCommercial Services Functions as a non profit that operates an incubator for startup businesses in science and technology | Directeur/Membre du Conseil | - |
Anciens postes connus de Martin N. Bonde
| Sociétés | Poste | Fin |
|---|---|---|
| STRATEGIC PARTNERS A/S | Directeur/Membre du Conseil | 23/05/2022 |
MycoTeQ A/S
 MycoTeQ A/S Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics | Directeur/Membre du Conseil | 02/04/2012 |
Inthera Bioscience AG
 Inthera Bioscience AG BiotechnologyHealth Technology Develops, manufactures small bio molecule therapies for solid tumors | Directeur Général | - |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ | - |
Formation de Martin N. Bonde
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Torsana A/S
 Torsana A/S Financial ConglomeratesFinance Engages in company incubation and development | Finance |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Develops and manufactures novel drugs | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Health Technology |
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Technology Services |
MycoTeQ A/S
MycoTeQ A/S Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics | Health Technology |
CelTor Biosystems, Inc.
 CelTor Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops clinical and life science instruments, consumables and software | Commercial Services |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Combio A/S | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Operates as an industry association for biotech companies with promoting the biotechnological research | Commercial Services |
Arpida A/S | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Strategic Partners A/S
 Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
Aros Pharma ApS
 Aros Pharma ApS Pharmaceuticals: MajorHealth Technology Develops a therapy for the treatment of gastrointestinal pain | Health Technology |
Biotopix ApS | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Develops, manufactures small bio molecule therapies for solid tumors | Health Technology |
Bohrs Towers IVS | |
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Finance |
Bohrs Tower ApS | |
Bii Holdings A/S
Bii Holdings A/S Miscellaneous Commercial ServicesCommercial Services Functions as a non profit that operates an incubator for startup businesses in science and technology | Commercial Services |
